CADTH has received notice of a pending resubmission from Eisai for palonosetron hydrochloride (Aloxi) capsules for the prevention of chemotherapy-induced nausea and vomiting.  For information about the patient input process or for additional instructions, please see the Patient Input page of the CADTH website. Note that only patient groups may submit input.

For more details, go to: http://www.cadth.ca/en/products/cdr/patient-group-input-form/396